AnaMariaVR2
Trusted Information Resource
As the Russian pharma industry continues to grow, the issue of improving manufacturing capacity and processes have become the top priority for key industry players in the market.
Under the "Pharma 2020" strategy, the Russian government intends to help existing local pharmaceutical companies finance R&D in order to increase production of innovative pharmaceuticals and to encourage the development of new local companies.
The most significant objective of the plan is to have local manufacturers producing 50% of the drugs available by 2020, of which 80% will be innovative drugs. Many international players are looking to set up their own manufacturing facilities or contract manufacture in the region in order not to miss out exciting opportunities this market has to offer.